Last edition
News about "Sathgen Therapeutics"
Sathgen Therapeutics Expands Global Footprint with US Subsidiary Launch
Sathgen Therapeutics has expanded its global presence with the launch of a US-based subsidiary, appointing Dr Padmaja Ganpathy as Chief Executive Officer and Dr Sendurai Mani as Chief Scientific Officer to lead its next phase of growth and innovation.
Sathgen Therapeutics | 18/12/2025 | By News Bureau | 166
Godavari Biorefineries Secures Chinese Patent for Novel Anti-Cancer Molecule
Godavari Biorefineries Ltd., through its biotech arm Sathgen Therapeutics, has been granted a Chinese patent for its novel anti-cancer molecule HYDROXY-1,4-NAPHTHALENEDIONE.
Sathgen Therapeutics | 22/07/2025 | By Mrinmoy Dey | 250
Godavari Biorefineries Ltd. has announced the validation of its European patent for a novel anti-cancer molecule in Spain, the UK, and as a Unitary Patent across multiple EU countries, marking a key milestone in its expansion into clinical-stage biotech and innovative cancer therapies.
Sathgen Therapeutics | 07/07/2025 | By Mrinmoy Dey | 130
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy